11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
about
Imaging of liver cancer.Adequate symptom relief justifies hepatic resection for benign diseasePrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationMolecular imaging and therapy targeting copper metabolism in hepatocellular carcinomaThe role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumorsNew approaches for precise response evaluation in hepatocellular carcinomaThe potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in TumorsDiagnostic and therapeutic management of hepatocellular carcinomaClinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumorSelection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantationTowards multidimensional radiotherapy: key challenges for treatment individualisation.Imaging metabolic heterogeneity in cancerApplication of dual phase imaging of 11C-acetate positron emission tomography on differential diagnosis of small hepatic lesions.Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationPET/CT in Oncology: Current Status and Perspectives.Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases11C-acetate PET imaging in patients with multiple sclerosis.Attacking the supply wagons to starve cancer cells to death.[(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinomaAcetate dependence of tumors.Imaging and cancer: a review.FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.Kinetic analysis of dynamic (11)C-acetate PET/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions.Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liverFamine versus feast: understanding the metabolism of tumors in vivo.The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignanciesImaging for assessment of treatment response in hepatocellular carcinoma: Current update.Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?Comparison of three ¹⁸F-labeled carboxylic acids with ¹⁸F-FDG of the differentiation tumor from inflammation in model mice.Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesionsCharacterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetatePre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?[(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in MiceThe evolving role of nuclear molecular imaging in cancer.FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CTMethodology for quantitative rapid multi-tracer PET tumor characterizations
P2860
Q24654739-6241AF67-4A4A-47E6-812E-750417C0B8C9Q24793256-FFC9CD84-E2C5-451A-8E68-90FB826DD472Q26772329-DC35E9C5-C2E4-4ECC-9ADA-72A3A7005A4FQ26772332-FFF8ECEA-3B65-4EE0-98F2-3A3FD145C0DBQ26823482-1F02568D-2332-4C6D-B754-C8D60954A0B4Q26866367-1A4B7EC6-FE0B-4417-AFB8-97F96E6BA4E8Q26996477-3C7D4CC2-37E1-482D-A011-58286EA37AC8Q26999043-1BC97A35-ABCD-44E0-93D8-83E27B5EED55Q27005824-D0C5DB30-FCC2-4084-806F-6B7E89D24433Q27014758-77A04133-5B81-43C7-B399-33E8E4AB8FE8Q27687218-DBA4ED47-37C7-418C-8A84-3508D5CBDA2DQ28076500-88E1E47D-C6C4-4AEC-8F7A-75070922B2D4Q33590285-7F160A4D-C331-4E70-A2FB-BD0F53B36525Q33594891-1D81BAA3-B3AE-482C-93A9-A39DDF4055D0Q33665109-384E7DCE-354F-4B97-9367-E6C4FB8BC939Q34083775-45495D92-C4D4-4925-B9F6-053EDEB7CD41Q34383286-39A09A7B-3B9C-4EE1-AF6B-9D56697F70F5Q34450336-4DCB592D-9955-42C1-8878-A4C45164D58FQ34516773-14EFC8A7-4241-4BF2-BC17-8294C90E0280Q34618851-678B1595-FAD0-4C83-8C5C-80142EFE7E0CQ34745657-B4A4BCA6-1B1F-4EF8-925D-73264831803DQ34977050-ADFD2C5E-F124-4C2C-9E52-2EB75D4FBD1BQ35000851-5914ACEF-4F80-40C9-A387-6EEAADEC06ADQ35086511-D6CBE61E-D24A-4190-B390-E7C3C72A78BBQ35112154-3CEA8C78-75E2-4089-93C5-589756729F21Q35122371-CA6DC050-0C69-4D35-94E1-1954CDBE2710Q35154056-4FE62FC9-B024-4F3C-A12C-6589BBC9100AQ35397108-FAE9724A-37B5-46ED-AEA1-5EEE8D83DFAFQ35568722-10DA9CC3-1043-4F17-AFCA-748A4FA7D656Q35633633-ECE09F69-C2FD-4EEB-965E-B22E84CDF852Q35861149-FD8ED8F4-9E9B-418F-A22B-F68E3FE3116BQ35891126-A1396D6E-965A-48B2-B02E-AE1FB2B5EF78Q36066047-EBFDD5A4-2088-48C5-A99D-50871093D2FDQ36570279-6D82AF67-7010-4A3F-BBB1-12E2ABE63FE6Q36687495-F1177098-BFC8-4C90-90DF-571F1A0C36FDQ36875442-BE1780C6-4F7A-4F9F-98BE-1D8B83CE451AQ36900941-DDCC7BEC-9595-48BE-B730-90D8633D1ACCQ37011086-282AC2C6-A98F-4167-9139-434A068EA725Q37077295-7CE43BE1-3440-451A-B99E-507B80A6CAF5Q37342653-0E6EB274-1BB1-4F2C-A8B6-10D3A084B08E
P2860
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@en
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@nl
type
label
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@en
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@nl
prefLabel
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@en
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
@nl
P2093
P1476
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses
@en
P2093
Chi-Lai Ho
David W C Yeung
Simon C H Yu
P304
P407
P577
2003-02-01T00:00:00Z